MANILA, Philippines — Chinese firms Sinovac Biotech and Clover Biopharmaceuticals may start Phase 3 of the clinical trials of their respective COVID-19 vaccines here by December or early January next year.
The two Chinese drugmakers are the first ones to pass evaluation of the country’s vaccine expert panel to conduct clinical trials of their candidate vaccine in the Philippines.
READ: After passing PH vaccine panel evaluation, Sinovac seeks FDA OK
Dr. Jaime Montoya, executive director of the Department of Science and Technology’s (DOST) Council for Health Research and Development, said the two Chinese firms are currently seeking the approval of the Single Joint Research Ethic…
Keep on reading: China’s Sinovac, Clover may start COVID-19 vax trials in PH by Dec. or early Jan. 2021